checkAd

Novo Nordisk Gets Label Extension Recommendation for Ozempic in Europe

(PLX AI) – Novo Nordisk says Ozempic 2.0 mg recommended for approval for the treatment of type 2 diabetes by the European Medicines Agency.European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive …

  • (PLX AI) – Novo Nordisk says Ozempic 2.0 mg recommended for approval for the treatment of type 2 diabetes by the European Medicines Agency.
  • European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending a label extension for the existing marketing authorization for Ozempic
  • Novo Nordisk expects a final approval by the European Commission within approximately two months, and Ozempic 2.0 mg will be launched in the EU in the first half of 2022
Wertpapier



0 Kommentare
Autor: PLX AI
12.11.2021, 12:01  |  333   |   |   

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

Novo Nordisk Gets Label Extension Recommendation for Ozempic in Europe (PLX AI) – Novo Nordisk says Ozempic 2.0 mg recommended for approval for the treatment of type 2 diabetes by the European Medicines Agency.European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive …

Nachrichten des Autors

Titel
Titel
Titel